# A Prospective, Non-Randomized Pivotal Clinical Investigation to Demonstrate the Safety and Performance of the TrueCross Single-Use Microcatheter

> **NCT06030271** · NA · COMPLETED · sponsor: **Insight Lifetech Co., Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Coronary Artery Disease Obliterative
- Chronic Total Occlusion (CTO)

## Interventions

- **DEVICE:** Microcatheter

## Key facts

- **NCT ID:** NCT06030271
- **Lead sponsor:** Insight Lifetech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-13
- **Primary completion:** 2023-03-30
- **Final completion:** 2023-03-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06030271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06030271, "A Prospective, Non-Randomized Pivotal Clinical Investigation to Demonstrate the Safety and Performance of the TrueCross Single-Use Microcatheter". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06030271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*